drugset / Trial / NCT01961934

C11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression

NCT01961934 ↗

Phase 2/3 Withdrawn Phoenix Molecular Imaging
NaSingle-groupOpen-labelDiagnostic

Summary

This study will investigate how well Carbon Acetate PET/CT imaging helps to correctly identify recurrent tumor versus post treatment effects (radionecrosis) in patients with previously treated high grade brain gliomas.

Timeline

Start
2014-05
Primary completion
2016-05
Completion
2018-05

Outcome

Outcome not reported

Stopped (Business): “Awaiting funding”

Drugs

EvaluationDrugModalityDoseRoute
Subject Carbon-11 Sodium Acetate Diagnostic / imaging agent — —

Indications